Quantcast
Channel: Reproductive Health Law | Beneficially Yours
Browsing all 7 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Coffee Talk With Benefits Episode 3: Employee Benefit Impact of Restrictions...

Should the recently leaked SCOTUS draft opinion overturning Roe v. Wade become law this summer, trigger laws across the Country will go into effect, illegalizing abortion in a significant number of...

View Article



Image may be NSFW.
Clik here to view.

Leaked Opinion Becomes Reality — Roe v. Wade is Overturned

Culminating a flurry of late June opinions released by SCOTUS this week, the court today in Dobbs v. Jackson Women’s Health Organization has taken the extraordinary step of ending decades of precedent...

View Article

Image may be NSFW.
Clik here to view.

Federal Government Response to Dobbs Begins to Take Shape

As we have been covering, the Supreme Court has overturned Roe v. Wade in their Dobbs v. Jackson Women’s Health Organization, leaving it to states to regulate access to abortion in their territory. The...

View Article

Image may be NSFW.
Clik here to view.

Equal Access to Travel Benefits

Seyfarth Synopsis: As more employers announce that they cover travel benefits under their medical plans that will allow participants to be reimbursed for certain travel expenses necessary in order to...

View Article

Introducing Seyfarth’s Reproductive Health Services Tracker on Survey Center

On June 24, 2022, the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health, overturning Roe v. Wade, abolishing the federal standard protecting the right to abortion. In the immediate...

View Article


Texas District Court Nullifies Portions of Preventive Care Mandate

Update: On June 13, 2023, the 5th Circuit issued a stay order which freezes the ruling issued by a Texas federal district court that voided the ACA requirement for health plans to cover preventive...

View Article

Dueling District Courts on Mifepristone: Texas Judge Suspends Approval While...

Seyfarth Synopsis: In an anticipated decision, released late on Friday April 7, 2023 of the Easter weekend, Texas District Court Judge Kacsmaryk has halted the FDA’s approval of Mifepristone. While in...

View Article
Browsing all 7 articles
Browse latest View live


Latest Images